Gov’t Commission authorised to set wholesale prices for pharmaceutical products
The latest move by the Georgian Government is designed to effect a reduction of domestic costs of medication. Photo: Government press office
Tweet 
Share
The Georgian Government’s Interagency Commission has been authorised to set wholesale prices for select pharmaceutical products by Prime Minister Irakli Garibashvili, in the latest move designed to effect a reduction of domestic costs of medication.
Citing “high public or state interest” in the mandate, the Government Administration said the Commission had also been allowed to regulate “other questions related to the market”, like terms and conditions for regulated costs, following “professional assessments”.
The country’s Health Ministry has been instructed to publish the updated prices on its catalogue, with the regulated costs coming into effect in a month from its release.
The Commission is composed of officials from the ministries of health, economy and finance, the Revenue Service, the National Intellectual Property Centre, the National Statistics Service and the National Competition Agency, along with two independent members from the pharmacy sector.
Starting from February 15, pharmacies, importers, distributors and retailers of medical drugs have been prohibited from selling medicines at prices exceeding the reference set by authorities.
The PM said in January the reference prices were expected to reduce prices by 40 percent this year, and highlighted the effects of the launch of imports of medical drugs produced in Turkey starting last year. He noted the earlier move had decreased costs for cardiovascular and other medicines in the country by 60-80 percent.
Garibashvili initially announced the initiative of his team to ensure a reduction of general prices of pharmaceuticals on the Georgian market through imports from Turkey in late 2021, citing the considerable gap between the lower cost of the GMP-manufactured drugs on the Turkish market and their counterparts in Georgia.
A Georgian delegation led by the country’s Prime Minister Irakli Garibashvili will feature in the World Economic Forum in Davos, with the Government head set to hold meetings with world leaders at the event.
Georgian Prime Minister Irakli Garibashvili on Monday said the reference price mechanism, set to be introduced in a Government initiative across Georgia next month, would reduce the cost of medical drugs by an average of 40 percent.
About 200 types of Good Manufacturing Practices (GMP)-standard drugs, imported from Turkey, will be available on the Georgian market in about a month, Deputy Health Minister Ilia Gudushauri said on Monday.
Georgia will import high-quality medicines from Turkey to effect a “significant” reduction of the cost of drugs on the Georgian market, Prime Minister Irakli Garibashvili said in a government session on Monday.
The Georgian Health Ministry on Thursday said it would have a “strict response” to “artificially increased prices” on expensive oncological medicines, after the “significant” surge of prices by “some” pharmaceutical companies.
The Georgian National Competition Agency on Monday said it had started inspecting four companies in the Georgian pharmaceutical market following “sharp increase” by them in prices of medicines for chronic and oncological illnesses.
Georgian Health Minister Zurab Azarashvili on Monday said the Ministry would finance "year-long medication needs" for oncology patients and was in talks with drug manufacturers.
Georgian Prime Minister Irakli Garibashvili, on Thursday, visited the first Drug Quality Control Laboratory in Georgia and said the Government had invested ₾11 million (about $4 mln) into the “ultra-modern” laboratory, which was essential for the Georgian people and the country.
The Regulation Agency for Medical and Pharmaceutical Activities of Georgia has “proactively” registered 563 medicines to simplify their import for domestic companies, the Ministry of Health announced on Friday.
A new bill will allow the Georgian Government to purchase “innovative” medical drugs at discounted prices, in a bid to improve access to the products for customers, the Government Administration revealed on Monday.
The number of medicines sold through the system of reference pricing across Georgia has been increased to 2,300, the Government Administration announced on Thursday. The list now included antihypertensive, anticoagulant, antihistaminic, antibiotic, gastrointestinal, analgesic and anti-inflammatory drugs.
Hans Kluge, the World Health Organisation’s Regional Director for Europe, has called reforms in Georgia for increasing accessibility to medicines “one of the best examples”, the Georgian Health Ministry said on Wednesday.
The Georgian Government on Monday announced an expansion in the drug programme for beneficiaries with chronic illnesses, as well as an increase in social assistance packages for disabled individuals, including children.